three-month period ended 31 March 2020 which has been reviewed by the Auditor. The overall of the Company’s performance can be summarised as follows: (Unit : Thousand Baht ) Performance (Income Statement

which is equal to the book value of PAF as the latest financial statement, which has been audited by the auditor as of 31 December 2019, has a total value of 11,488,125 baht , which is the value agreed

to final the relevant details, documentations, and/or actions for Overallotment Agreement and/or CCPT-KY Plan as deem appropriate. The IPO Plan and the Optional Shares will dilute the Company’s

than 3 years in middle size in value more than 0.03% but less than 3% of book value of Net Tangible Assets (the reviewed of the consolidated financial statement as at 31 March 2020). Therefore, the

property leasing for not more than 3 years in middle size in value more than 0.03% but less than 3% of book value of Net Tangible Assets (the reviewed of the consolidated financial statement as at 31 March

recognized impairment loss on goodwill in the amount of Baht 37.90 million in consolidated statement and impairment loss on subsidiaries investment in the amount of Baht 133.00 million in separate financial

transactions within the past 6 months, is equivalent to 16.65 percent that based on the value of total assets in consolidated financial statement ended December 31 st , 2017. This 16.65 percent transaction size

2020, ended June 30, 2020 The operating results of the Company and its subsidiaries for the second quarter of 2020, ended June 30, 2020 was described in the financial statement showing net loss at the

the company’s 2019 performance to the shareholders Agenda 3 Approve the audited financial statement for the year ended 31 December 2019. Opinion of the Board of Directors See as appropriate for the

sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the